bluebird bio to Host Third Quarter 2023 Financial Results Conference Call
24 Ottobre 2023 - 2:00PM
Business Wire
bluebird bio, Inc. (Nasdaq: BLUE) announced today that it
will host a conference call to discuss third quarter 2023 financial
results and business updates on Tuesday, November 7 at 8:00 a.m.
ET.
To access the call via telephone, please register at this link
https://edge.media-server.com/mmc/p/cq4tzukh to receive a dial in
number and unique PIN to access the live conference call.
The live webcast of the call may be accessed by visiting the
“Events & Presentations” page within the Investors & Media
section of the bluebird website at http://investor.bluebirdbio.com.
A replay of the webcast will be available on the bluebird website
for 90 days following the event.
About bluebird bio, Inc.
bluebird bio is pursuing curative gene therapies to give
patients and their families more bluebird days.
With a dedicated focus on severe genetic diseases, bluebird has
industry-leading programs for sickle cell disease, β-thalassemia
and cerebral adrenoleukodystrophy and is advancing research to
apply new technologies to these and other diseases. We custom
design each of our therapies to address the underlying cause of
disease and have developed in-depth and effective analytical
methods to understand the safety of our lentiviral vector
technologies and drive the field of gene therapy forward.
Founded in 2010, bluebird has the largest and deepest ex-vivo
gene therapy data set in the world—setting the standard for the
industry. Today, bluebird continues to forge new paths, combining
our real-world experience with a deep commitment to patient
communities and a people-centric culture that attracts and grows a
diverse flock of dedicated birds.
For more information, visit bluebirdbio.com or follow us
on social media at @bluebirdbio, LinkedIn,
Instagram and YouTube.
bluebird bio is a trademark of bluebird bio, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231024153256/en/
Investors:
Courtney O’Leary, 978-621-7347 coleary@bluebirdbio.com
Media:
Jess Rowlands, 857-299-6103 jess.rowlands@bluebirdbio.com
Grafico Azioni bluebird bio (NASDAQ:BLUE)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni bluebird bio (NASDAQ:BLUE)
Storico
Da Apr 2023 a Apr 2024